Enzo Biochem to be acquired by Battery Ventures for 70c per share in cash
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 24 2025
0mins
Should l Buy ?
Merger Announcement: Enzo Biochem has entered into a merger agreement with Battery Ventures, where Battery will acquire Enzo for $0.70 per share in cash, totaling approximately $37 million, which is a 75% premium over the company's closing price on April 22.
Transaction Details: The merger is subject to customary closing conditions, including shareholder approval, and is expected to close in the third quarter of the year, after which Enzo will become privately held and its shares will be delisted from public markets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
